cyc 202 has been researched along with paclitaxel in 16 studies
| Studies (cyc 202) | Trials (cyc 202) | Recent Studies (post-2010) (cyc 202) | Studies (paclitaxel) | Trials (paclitaxel) | Recent Studies (post-2010) (paclitaxel) |
|---|---|---|---|---|---|
| 979 | 7 | 393 | 31,874 | 5,729 | 15,395 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (6.25) | 18.2507 |
| 2000's | 8 (50.00) | 29.6817 |
| 2010's | 5 (31.25) | 24.3611 |
| 2020's | 2 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Bilter, GK; Dias, J; Huang, Z; Keon, BH; Lamerdin, J; MacDonald, ML; Michnick, SW; Minami, T; Owens, S; Shang, Z; Westwick, JK; Yu, H | 1 |
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Beauchard, A; Besson, T; Ferandin, Y; Guguen-Guillouzo, C; Laborie, H; Le Guével, R; Lozach, O; Meijer, L; Rouillard, H; Thiéry, V | 1 |
| Austin, CP; Fidock, DA; Hayton, K; Huang, R; Inglese, J; Jiang, H; Johnson, RL; Su, XZ; Wellems, TE; Wichterman, J; Yuan, J | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Brown, ML; Dakshanamurthy, S; Deb, TB; Grindrod, SC; Paige, M; Yang, Y; Yenugonda, VM | 1 |
| Babu, KS; Bondon, A; Boustie, J; Ferron, S; Graton, J; Jacquemin, D; Le Lamer, AC; Le Pogam, P; Legouin, B; Obermayer, W; Rouaud, I; Siva, B | 1 |
| Dilasser, F; Dubreuil, D; Le Gall, E; Le Guével, R; Lebreton, J; Léonel, E; Loirand, G; Martens, T; Pipelier, M; Rousselle, M; Sauzeau, V; Sengmany, S; Sitter, M | 1 |
| Aparna, P; Bach, S; Baratte, B; Brahmaiah, D; Grée, R; Kanaka Durga Bhavani, A; Le Guevel, R; Levoin, N; Mosset, P; Raji Reddy, C; Roisnel, T; Ruchaud, S; Sampath Kumar, N; Singh Jadav, S; Solhi, H | 1 |
| Binarova, P; Bögre, L; Calderini, O; Heberle-Bors, E; Vicente, O; Wilson, C | 1 |
| Dangi, S; Shapiro, P | 1 |
| Fernando, R; Foster, JS; Henley, D; Isbill, M; Wimalasena, J | 1 |
| McNeely, SC; States, JC; Taylor, BF | 1 |
| Abaza, MS; Al-Attiyah, RJ; Bahman, AM | 1 |
| Chen, Y; Dong, J; Ji, M; Xiao, L; Yang, S; Zhang, L | 1 |
| Sakai, M; Yoshimura, R | 1 |
16 other study(ies) available for cyc 202 and paclitaxel
| Article | Year |
|---|---|
Identifying off-target effects and hidden phenotypes of drugs in human cells.
Topics: Bacterial Proteins; Cell Line; Cell Proliferation; Cluster Analysis; Drug Design; Drug Evaluation, Preclinical; Genetics; Humans; Luminescent Proteins; Molecular Structure; Phenotype; Recombinant Fusion Proteins; Signal Transduction; Structure-Activity Relationship | 2006 |
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Synthesis and kinase inhibitory activity of novel substituted indigoids.
Topics: Alzheimer Disease; Casein Kinase I; Cyclin B1; Cyclin-Dependent Kinase 5; Dyrk Kinases; Glycogen Synthase Kinase 3; Humans; Indoles; Neuroprotective Agents; Protein Kinase Inhibitors; Protein Kinases; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases | 2009 |
Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum.
Topics: Animals; Antimalarials; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chromosome Mapping; Crosses, Genetic; Dihydroergotamine; Drug Design; Drug Resistance; Humans; Inhibitory Concentration 50; Mutation; Plasmodium falciparum; Quantitative Trait Loci; Transfection | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Fluorescent cyclin-dependent kinase inhibitors block the proliferation of human breast cancer cells.
Topics: Adenine; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Cyclin-Dependent Kinases; Dansyl Compounds; Female; Fluorescent Dyes; Humans; Protein Kinase Inhibitors | 2011 |
Minor Pyranonaphthoquinones from the Apothecia of the Lichen Ophioparma ventosa.
Topics: Antineoplastic Agents; Biphenyl Compounds; Circular Dichroism; Drug Screening Assays, Antitumor; Fruiting Bodies, Fungal; Humans; Inhibitory Concentration 50; Lichens; Molecular Structure; Naphthoquinones; Nuclear Magnetic Resonance, Biomolecular; Picrates; Pyrans | 2016 |
Synthesis and biological evaluation of 3-amino-, 3-alkoxy- and 3-aryloxy-6-(hetero)arylpyridazines as potent antitumor agents.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Drug Screening Assays, Antitumor; Humans; Pyridazines | 2019 |
Discovery of DB18, a potent inhibitor of CLK kinases with a high selectivity against DYRK1A kinase.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Discovery; Drug Screening Assays, Antitumor; Dyrk Kinases; Humans; Molecular Structure; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases; Structure-Activity Relationship | 2021 |
A cell cycle regulated MAP kinase with a possible role in cytokinesis in tobacco cells.
Topics: Anaphase; Benzamides; Calcium-Calmodulin-Dependent Protein Kinases; Cell Cycle Proteins; Cell Line; Cyclin-Dependent Kinases; Enzyme Activation; Enzyme Inhibitors; Fluorescent Antibody Technique, Indirect; Fungal Proteins; Immunoblotting; Metaphase; Microtubules; Mitogen-Activated Protein Kinases; Mitosis; Nicotiana; Nitrobenzenes; Organothiophosphorus Compounds; Paclitaxel; Plant Proteins; Plants, Toxic; Protein Kinases; Purines; Roscovitine; Schizosaccharomyces pombe Proteins; Telophase | 1998 |
Cdc2-mediated inhibition of epidermal growth factor activation of the extracellular signal-regulated kinase pathway during mitosis.
Topics: CDC2 Protein Kinase; Cell Line, Tumor; Densitometry; Enzyme Activation; Epidermal Growth Factor; Extracellular Signal-Regulated MAP Kinases; Guanine Nucleotide Exchange Factors; HeLa Cells; Humans; Immunoblotting; Immunoprecipitation; Mitosis; Models, Biological; Nocodazole; Paclitaxel; Phosphorylation; Protein Binding; Protein Biosynthesis; Proto-Oncogene Proteins c-raf; Purines; Roscovitine; Signal Transduction; SOS1 Protein; Tetradecanoylphorbol Acetate; Time Factors; Transcription, Genetic; Vinblastine | 2005 |
Paclitaxel induced apoptosis in breast cancer cells requires cell cycle transit but not Cdc2 activity.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; bcl-Associated Death Protein; Blotting, Western; Breast Neoplasms; CDC2 Protein Kinase; Cell Cycle; Cell Line, Tumor; Cell Nucleus; Cell Survival; DNA Fragmentation; Estradiol; Flow Cytometry; Fulvestrant; Humans; Hydroxyurea; Inhibitor of Apoptosis Proteins; JNK Mitogen-Activated Protein Kinases; Microtubule-Associated Proteins; Microtubules; Neoplasm Proteins; Paclitaxel; Purines; RNA, Small Interfering; Roscovitine; Spindle Apparatus; Survivin; Thymidine; Transfection | 2007 |
Mitotic arrest-associated apoptosis induced by sodium arsenite in A375 melanoma cells is BUBR1-dependent.
Topics: Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Apoptosis; Arsenites; Blotting, Western; CDC2 Protein Kinase; Fluorescent Antibody Technique; Humans; Melanoma, Experimental; Mitosis; Nocodazole; Paclitaxel; Protein Serine-Threonine Kinases; Purines; RNA, Small Interfering; Roscovitine; Sodium Compounds | 2008 |
Roscovitine synergizes with conventional chemo-therapeutic drugs to induce efficient apoptosis of human colorectal cancer cells.
Topics: Adenocarcinoma; Antineoplastic Agents; Apoptosis; Cell Cycle; Cell Line, Tumor; Colorectal Neoplasms; DNA Fragmentation; Dose-Response Relationship, Drug; Doxorubicin; Drug Synergism; Drug Therapy, Combination; Fluorouracil; Humans; Paclitaxel; Purines; Roscovitine; Time Factors; Vinblastine | 2008 |
Phospho-regulation of KIBRA by CDK1 and CDC14 phosphatase controls cell-cycle progression.
Topics: Amino Acid Sequence; Binding Sites; CDC2 Protein Kinase; Cell Cycle Checkpoints; Cell Line, Tumor; Cyclin B; Dual-Specificity Phosphatases; HEK293 Cells; HeLa Cells; Humans; Intracellular Signaling Peptides and Proteins; MAP Kinase Signaling System; Molecular Sequence Data; Paclitaxel; Phosphoproteins; Phosphoric Monoester Hydrolases; Phosphorylation; Protein Tyrosine Phosphatases; Purines; Recombinant Fusion Proteins; Roscovitine | 2012 |
Mechanotransduction-Targeting Drugs Attenuate Stiffness-Induced Hepatic Stellate Cell Activation in Vitro.
Topics: Actins; Adenosine Triphosphate; Animals; Benzamides; Cells, Cultured; Colchicine; Collagen Type I; Hepatic Stellate Cells; Imidazoles; Integrins; Male; Mechanotransduction, Cellular; Paclitaxel; Piperazines; Pyrazines; Quinoxalines; Rats, Sprague-Dawley; Roscovitine; Sulfonamides; Transforming Growth Factor beta; Tubulin Modulators | 2021 |